Antiphospholipid (aPL) antibodies: A meta-analysis of over 1159 patients reported that aPL antibodies were detected in nearly half of patients with COVID-19, with a higher prevalence of aPL found in those with severe disease. The gene discussed is FASLG; the disease is COVID-19.